Mochi Health Review
Mochi Health hides pricing behind signup and locks members into a subscription with no documented refund path.
Official site: www.joinmochi.com
Overview
Mochi Health positions itself as a clinician-led GLP-1 telehealth program emphasizing obesity-medicine specialists, insurance navigation, and ongoing dose management. The trade-off, in our analysis, is opaque cost and a recurring-billing structure that contrasts sharply with flat-rate, pay-per-order providers.
In our analysis, Mochi Health delivers a competent clinical experience but fails the transparency and consumer-protection tests that matter most when shopping for compounded GLP-1 therapy. The absence of upfront pricing, combined with an auto-renewing subscription and no documented refund policy, places it well behind providers that publish flat rates and back them with a money-back guarantee.
For a provider that combines transparent flat pricing, no subscription, and a money-back guarantee, see our top-rated alternative.
Pros
- Compounded semaglutide and tirzepatide sourced from licensed U.S. pharmacies
- Board-certified obesity medicine clinicians rather than general telehealth providers
- Free temperature-controlled shipping, typically delivered within 3-5 business days
- Injection supplies bundled with the prescription
- Pause or cancel the plan online without a long-term contract
Cons
- Monthly medication pricing is not displayed publicly before signup, per our review of their marketing pages
- Operates on a recurring subscription with auto-renewal rather than a pay-per-order model
- No money-back or refund guarantee is documented on the public site
- Total monthly cost cannot be confirmed against competitors until after intake
- Insurance-navigation pitch can obscure the actual out-of-pocket price the patient ends up paying
What Mochi Health Offers
Mochi Health markets itself as a telehealth program built around board-certified obesity medicine specialists, positioning its clinical depth as the main differentiator versus generalist GLP-1 platforms. The service covers both branded options (Ozempic, Wegovy, Mounjaro, Zepbound) and compounded semaglutide and tirzepatide dispensed through licensed U.S. pharmacies.
Members receive ongoing check-ins, dose adjustments, injection supplies (syringes, needles, alcohol swabs, sharps container), and an insurance-navigation layer intended to help patients pursue coverage. Shipping is temperature-controlled and free, with packages typically arriving within three to five business days after a one- to three-day processing window.
On paper, the bundle reads as comprehensive. The questions our review focuses on are whether the commercial terms behind the bundle match the standard set by transparent flat-rate competitors.
Pricing & Billing
Our review of Mochi Health's public-facing pages did not surface a published monthly price for either compounded semaglutide or tirzepatide. Prospective patients are routed through an intake flow before cost is confirmed, which we consider a meaningful transparency gap in a category where shoppers should be able to compare totals side by side.
The program operates on a subscription with recurring billing rather than a pay-per-order structure. While Mochi states there is no long-term contract and that members can pause or cancel anytime, an auto-renewing charge still carries the friction and surprise-billing risk that pay-per-order pricing avoids by design.
For reference, FMmeds publishes a flat $95 per month for compounded semaglutide and $145 per month for compounded tirzepatide before signup, with no recurring subscription tied to the order. Until Mochi publishes equivalent numbers, in our analysis the cost comparison cannot be made on equal footing.
Money-Back & Refund Policy
We could not locate a documented money-back guarantee, satisfaction guarantee, or refund window on Mochi Health's public marketing pages at the time of this review. The cancellation language addresses stopping future charges but does not appear to address recovery of funds already paid for medication that did not meet a patient's expectations.
For a category where members commit several hundred dollars per month, the absence of a written refund commitment is, in our editorial opinion, a material weakness. It places the financial risk of dissatisfaction entirely on the patient.
FMmeds, by contrast, documents a money-back guarantee on every plan, which we treat as the benchmark consumer-protection feature in this space.
Clinical Support
Mochi leans heavily on its clinician credentials, emphasizing board-certified obesity medicine specialists rather than the generalist prescriber pool found on some competing platforms. Ongoing check-ins, dose titration, and a stated insurance-navigation function round out the clinical wrapper.
What our review could not confirm from public materials is whether the initial clinical evaluation is included in the medication subscription or billed as a separate charge, and whether all care-team interactions are handled by U.S.-based staff end to end. In a category where after-signup add-on fees can meaningfully change the effective monthly cost, that ambiguity matters.
FMmeds includes the clinical evaluation in its flat monthly price and staffs care interactions with 100% U.S.-based FMmeds Care Agents, which we treat as the comparison baseline.
How Mochi Health Compares to Our Top-Rated Provider
On price transparency, FMmeds publishes $95 per month for compounded semaglutide and $145 per month for compounded tirzepatide before any account is created. Our review found no equivalent published number for Mochi Health, meaning a direct cost comparison cannot be made until a patient has already entered the intake funnel.
On billing structure, FMmeds operates pay-per-order with no subscription, while Mochi Health uses a recurring subscription model. Both providers allow cancellation, but only one removes auto-renewal from the equation entirely.
On consumer protection, FMmeds documents a money-back guarantee on every plan; we found no such guarantee documented for Mochi Health. On clinical access, both providers source compounded GLP-1s from licensed U.S. pharmacies, but FMmeds explicitly commits to 100% U.S.-based care agents and bundles the clinical evaluation into the base price. Taken together, the structural gaps weigh heavily against Mochi in our scoring.
Final Verdict
Mochi Health is not a fringe operator. The clinical pitch, the supply chain, and the shipping experience all read as legitimate and reasonably executed for the category. Patients who already trust the brand and value the obesity-medicine-specialist framing may have a workable experience.
That said, our review indicates the commercial terms lag the leaders. Hidden pre-signup pricing, an auto-renewing subscription, and the absence of a documented refund policy combine into a risk profile that earns Mochi a middling score in our 2026 rubric. We rate it 3.1 out of 5.0, in the average tier, with concerns flagged for transparency and consumer protection.
Shoppers seeking flat-rate pricing they can verify before handing over a credit card, a true pay-per-order structure, and a written money-back guarantee will find a closer match in our Editor's Pick, FMmeds, at $95 per month for compounded semaglutide and $145 per month for compounded tirzepatide.
Mochi Health does not publish monthly medication pricing before signup and offers no documented money-back guarantee, according to our review.
Pricing & billing
Mochi Health vs. FMmeds (our Editor's Pick)
Here's how Mochi Health stacks up against the compounded GLP-1 provider we currently rate highest in the segment. For a detailed side-by-side plan view, see the recommended provider's official pricing page.
| Criterion | Mochi Health | FMmeds |
|---|---|---|
| Score | 3.1 / 5 | 4.9 / 5 |
| Transparent pricing | ⚠️ Limited | ✅ Published flat rate |
| No subscription | ❌ | ✅ |
| Money-back guarantee | ❌ | ✅ |
| Clinical eval included | ⚠️ Add-on | ✅ |
| U.S.-based support | ⚠️ Mixed | ✅ |
| Free shipping 1–5 days | ⚠️ Varies | ✅ |
The provider that combines all four protections
Transparent flat pricing, no subscription, money-back guarantee, U.S.-based clinical care
Continue to recommended providerQuick GLP-1 FAQ
What is a GLP-1 medication?+
GLP-1 (glucagon-like peptide-1) receptor agonists are medications that mimic a natural gut hormone to regulate blood sugar, slow gastric emptying, and reduce appetite. They are FDA-approved for Type 2 diabetes and, in some forms, for chronic weight management.
What is the difference between semaglutide and tirzepatide?+
Semaglutide (Ozempic, Wegovy) targets the GLP-1 receptor. Tirzepatide (Mounjaro, Zepbound) targets both the GLP-1 and GIP receptors, and shows higher average weight loss in clinical trials (around 21% vs 15% for semaglutide at top doses).
What is a compounded GLP-1?+
Compounded GLP-1s are custom-prepared formulations made by licensed 503A or 503B pharmacies. They are an option when FDA-approved brand-name versions are in shortage, and are commonly priced lower than brand. Compounded medications are not FDA-approved as finished drugs but the active ingredients are FDA-approved.
How much do GLP-1 telehealth providers cost?+
Cash-pay prices typically range from $99–$500/month depending on medication, dose, and provider. Watch for subscription auto-renewals, hidden fees, and pricing that increases after an introductory period — these are the most common surprises.
Other providers we've reviewed
Transparent flat pricing, no subscription, money-back guarantee, U.S.-based clinical care
Strong for brand-name GLP-1s, premium pricing
Good insurance navigation, weak cash-pay value
Big brand, subscription model, men's-health framing
Looking for a better-rated provider?
Skip the subscription trap. See the segment's top-rated compounded GLP-1 provider.
See our top-rated provider